Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials

Sexually Transmitted Diseases

Volumn 32, Issue 8, 2005, Pages 491-494

  Moncla, Bernard J ^a   Hillier, Sharon L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; NONOXINOL 9; SPERMICIDAL AGENT;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHLAMYDIA TRACHOMATIS; GONORRHEA; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION PREVENTION; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS INERS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN;

CLINICAL TRIALS; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; NONOXYNOL; PENNSYLVANIA; RESEARCH DESIGN; SPERMATOCIDAL AGENTS; VAGINAL SMEARS;

EID: 23044480865     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000170444.13666.e9     Document Type: Article

References (29)

1. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82:454-461.
2. Wilkinson D, Tholandi M, Ramjee G, et al. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomized controlled trials including more than 5000 women. Lancet Infect Dis 2002; 2:613-617.
3. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 acquisition in female sex workers: a randomised controlled trial. Lancet 2002; 360:971-977.
4. Benes S, McCormack WM. Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agent Chemother 1985; 27:724-726.
5. Bolch OH, Warren JC. In vitro effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis. Am J Obstet Gynecol 115:1145-1148, 1973.
6. Cowan ME, Cree E. A note on the susceptibility of N. gonorrhoeae to contraceptive agent nonyl-P. Br J Vener Dis 1973; 49:65-66.
7. Patton DL, Kidder GG, Sweeney YC, et al. Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model. Sex Transm Dis 1996; 23:461-464.
8. Singh B, Cutler JC, Utidjian HMD. Studies on the development of a vaginal preparation providing both prophylactics and contraception, II: effect in vitro of vaginal contraceptive and non-contraceptive preparation on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis 1972; 48:57-63.
9. Kelly JP, Reynalds RB, Stagno S, et al. In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antmicrob Agents Chemother 1985; 27:760-762.
10. Miller CJ, Alexander WJ, Gettie A, et al. The effect of contraceptives containing nonoxynol-9 on genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril 1992; 57:1126-1128.
11. Polsky B, Baron PA, Gold JWM, et al. In vivo inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. Lancet 1988; 1:1456.
12. Rosenberg M, Rojanapithayakorn W, Feldblum P, et al. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: a comparative clinical trial. JAMA 1987; 257:2308-2312.
13. Austin HW, Louv WC, Alexander J. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
14. Jick H, Hannan MT, Stergachis A, et al. Vaginal spermicides and gonorrhea. JAMA 1982; 248:1619-1621.
15. Weir SS, Feldblum PJ, Sekeng L, et al. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994; 84:910-914.
16. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-1375.
17. Louv WC, Austin H, Alexander WJ, et al. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-523.
18. Richardson BA, Lavreys L, Martin ML, et al. Evaluation of low-dose nonoxynol-9 for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis 2001; 28:394-400.
19. Roddy RE, Zekeng L, Ryan RA, et al. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. JAMA 2002; 287:1117-1122.
20. Roddy RE, Zekeng L, Ryan KA, et al. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339:504-510.
21. Witter FR, Barditch-Crovo P, Rocco L, et al. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives. Int J Gyn Obstet 1999; 65:165-170.
22. Rabe LK, Hillier SL. Effect of chlorhexidine on genital microflora, Neisseria gonorrhoeae, and Trichomonas vaginalis in vitro. Sex Transm Dis 2000; 27:74-78.
23. Cosentino LA, Landers DV, Hillier SL. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control fro use with vaginal swab specimens. J Clin Microbiol 2003; 41:3592-3596.
24. Antonio MA, Hawes L, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999; 180:1950-1956.
25. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. 6th ed. (M7-A6). Wayne, Pa: National Committee for Clinical Laboratory Standards; 2003.
26. Hooton TM, Fennnel CL, Clark AM, et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. J Infect Dis 1991; 164:164-169.
27. McGroarty JA, Tomeczek L, Pond DG, et al. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis 1992; 165: 1142-1144.
28. Watts DH, Rabe L, Krohn MA, et al. The effect of three nonoxynol-9 preparations on vaginal flora and epithelium. J Infect Dis 1999; 180:426-437.
29. Kreiss J, Ngugi E, Homes KK, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268:477-482.